ZetrOZ
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, ZetrOZ sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
ZetrOZ: 17 sponsored US clinical trials, 3 recruiting.
ZetrOZ sponsors 17 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 11 completed. 0 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Arthritis, with 3 trials.
Top-decile sponsor footprint
ZetrOZ ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
11 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
NCT06257537
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
NCT05883241
Sustained Acoustic Medicine for Osteoarthritis Pain
NCT05254574
Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis
NCT07515872
Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation
NCT06510062
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
NCT05882812
Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance
NCT05259995
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
NCT05050448
Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care
NCT05254470
Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis
NCT04391842
Long-Duration Ultrasound for Knee Osteoarthritis
NCT03800927
Sustained Acoustic Medicine for Chronic Low Back Pain Secondary to Herniated Nucleus Pulposus or Other Conditions
NCT02609854
Long Duration Therapeutic Ultrasound on Tendon Injuries
NCT02340273
Low Intensity Ultrasound Therapy for Upper Back Pain Relief
NCT02135094
Wearable LITUS Device for Osteoarthritis of the Knee: a Randomized Double-Blind Placebo-Controlled Trial
NCT02083861
Long Duration Therapeutic Ultrasound for Tendon Healing
NCT02466308
Wearable Therapeutic Ultrasound Study for Knee Osteoarthritis
NCT01993693
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 3 |
What is open in the ZetrOZ pipeline
3 recruiting of 17 indexed (18% open); 11 completed (65%).
Phase mix: 0 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Arthritis (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ZetrOZ: open-pipeline peers nationwide
Peers matched on 17 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
ZetrOZ sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
- Sanford Health · 18% recruiting · 34 trials
Related
What to do with this ZetrOZ page
17 registered trials is a research-attention snapshot, not an endorsement of ZetrOZ or any single study.
- 3 of ZetrOZ's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Arthritis is the condition ZetrOZ studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Arthritis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ZetrOZ pipeline card: 17 registered trials from official public datasets.Report a data error.